title: Chemical modifications of the vasoconstrictor peptide angiotensin II by nitrogen oxides (NO, HNO2, HOONO)--evaluation by mass spectrometry.
abstract: Nitric oxide (NO) and angiotensin II are natural regulators of blood pressure. Under aerobic conditions, NO is transformed into its higher oxides (N2O4, NO2, NO/NO2 or N2O3) and oxoperoxonitrate (currently named peroxynitrite) by coupling with superoxide. Previous studies have shown that these reactive nitrogen species should be involved in vivo in the transformation of cysteine and tyrosine into the corresponding nitrosothiol and 3-nitrotyrosine. In the present study, attention has been focused on the relative reactivities of HNO2, peroxynitrite, and NO in the presence of dioxygen, towards the arginine and tyrosine residues of the peptide angiotensin II. Nitration of the tyrosine residue is clearly the main reaction with peroxynitrite. By contrast, besides 20% of nitration of the tyrosine residue, NO in the presence of dioxygen leads to nitrosation reactions with the arginine residue similar to those observed with HNO2 at pH 5, possibly through the intermediate N2O3 reactive species. Angiotensin II is converted for the most part to peptides having lost either a terminal amine function or the whole guanido group, leading respectively to citrulline-containing angiotensin II or to a diene derivative. Identification established mainly by tandem mass spectrometry of peptidic by-products allows us to propose a cascade of nitrosations of all the amine functions of the arginine residue. Further in vivo studies show that transformations of the arginine residue in angiotensin II do not alter its vasoconstrictive properties, whereas nitration of the tyrosine residue totally inhibits them.
authors.affiliation: Institut de Chimie des Substances Naturelles, CNRS, Gif-sur-Yvette, France. claire.ducrocq@icsn.cnrs-gif.fr
authors.forename: C
authors.initials: C
authors.lastname: Ducrocq
authors.forename: M
authors.initials: M
authors.lastname: Dendane
authors.forename: O
authors.initials: O
authors.lastname: Laprévote
authors.forename: L
authors.initials: L
authors.lastname: Serani
authors.forename: B C
authors.initials: BC
authors.lastname: Das
authors.forename: N
authors.initials: N
authors.lastname: Bouchemal-Chibani
authors.forename: B T
authors.initials: BT
authors.lastname: Doan
authors.forename: B
authors.initials: B
authors.lastname: Gillet
authors.forename: A
authors.initials: A
authors.lastname: Karim
authors.forename: A
authors.initials: A
authors.lastname: Carayon
authors.forename: D
authors.initials: D
authors.lastname: Payen
mesh_terms: D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000737:chemistry; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D015394:Molecular Structure; D008970:Molecular Weight; D009566:Nitrates / Q000494:pharmacology; D009589:Nitrogen Oxides / Q000494:pharmacology; D016877:Oxidants / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014661:Vasoconstriction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000737:chemistry* / Q000494:pharmacology
chemical_list: D009566:Nitrates; D009589:Nitrogen Oxides; D016877:Oxidants; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; C039642:peroxynitric acid; D001120:Arginine